[CAS NO. 944842-54-0]  Decernotinib (VX-509)

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [944842-54-0]

Store
Catalog
SLK-S7541
Brand
Selleck
CAS
944842-54-0

DESCRIPTION [944842-54-0]

Overview

MDLMFCD27987896
Molecular Weight392.38
Molecular FormulaC18H19F3N6O
SMILESN([C@@](C(NCC(F)(F)F)=O)(CC)C)C1=NC(C=2C=3C(NC2)=NC=CC3)=NC=C1

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.5485 mL12.7427 mL25.4855 mL
5 mM0.5097 mL2.5485 mL5.0971 mL
10 mM0.2549 mL1.2743 mL2.5485 mL
50 mM0.0510 mL0.2549 mL0.5097 mL

Description

Decernotinib (VX-509) is a potent and selective inhibitor with of 2.5 nM, >4-fold selectivity over JAK1, JAK2, and TYK2, respectively. Phase 2/3.

Targets

JAK3 [1]JAK1 [1]JAK1 [1]JAK2 [1]TYK2 [1]
2.5 nM(Ki)11 nM11 nM(Ki)13 nM(Ki)13 nM(Ki)

In vitro

In HT-2 cells, Decernotinib inhibits IL-2–stimulated HT-2 STAT-5 phosphorylation, human T-cell blast proliferation, and CD40L/IL-4–induced B-cell proliferation.

In vivo

In a rat model of collagen-induced arthritis, VX-509 (50 mg/kg, p.o.) results in dose-dependent reduction in ankle swelling and paw weight and improved paw histopathology scores. In a mouse model of oxazolone-induced delayed-type hypersensitivity, VX-509 (50 mg/kg, p.o.) significantly suppresses ear edema. In a rat HvG model, VX-509 (50 mg/kg, p.o.) results in dose-dependent inhibition of popletial lymph node (PLN) hyperplasia.


Synonyms

Butanamide, 2-methyl-2-[[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)-4-pyrimidinyl]amino]-N-(2,2,2-trifluoroethyl)-, (2R)-
(2R)-2-Methyl-2-[[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)-4-pyrimidinyl]amino]-N-(2,2,2-trifluoroethyl)butanamide
VRT 831509
VX 509
Decernotinib
V 509
(2R)-2-Methyl-2-[[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-N-(2,2,2-trifluoroethyl)butanamide